The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...

The Janus Henderson Mid Cap Growth Managed Account Portfolio returned -0.05% (gross) for Q4 2024. Click here to read the full ...

In today’s fast-paced world, maintaining optimal health is paramount, especially for men who may face unique health ...

For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...

In recent years, there has been a noticeable increase in the number of men seeking natural remedies for prostate health. With ...

For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...

Austin Chiang, MD, MPH: One innovation that's happening in my specialty of gastroenterology is artificial intelligence. Ben ...

When patients can’t access their MHT patches, they may consider switching to different formulations, such as tablets or gels.

Despite the recent launch of congenital adrenal hyperplasia (CAH) drug Crenessity, Neurocrine Biosciences' disappointing ...

Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Fourth Quarter and Full Year 2024 Results Conference ...